Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: A hypothesis-generating study

Cancer Causes and Control

Volumn 20, Issue 5, 2009, Pages 591-599

  Crous Bou, Marta ^a,b   Porta, Miquel ^a,b   Morales, Eva ^a   López, Tomàs ^a,b   Carrato, Alfredo ^c   Puigdomènech, Elisa ^a,b   Real, Francisco X ^a,d,e  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Diabetes mellitus; Etiology; K ras oncogene; Medical conditions; Pancreatic ductal adenocarcinoma; Pancreatic neoplasms; Pancreatitis; Peptic ulcer

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE PANCREATITIS; ANAMNESIS; ARTICLE; CARCINOGENESIS; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIABETES MELLITUS; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PEPTIC ULCER; PRIORITY JOURNAL;

CARCINOMA, PANCREATIC DUCTAL; GENES, RAS; HUMANS; INTERVIEWS AS TOPIC; MEDICAL HISTORY TAKING; MUTATION; PANCREATIC NEOPLASMS; PANCREATITIS; PEPTIC ULCER;

EID: 67349171678     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9267-x     Document Type: Article

References (50)

1. Ekbom A, Hunter D (2002) Pancreatic cancer. In: Adami HO, Hunter D, Trichopoulos D (eds) Textbook of cancer epidemiology. Oxford University Press, New York, pp 233-247
2. Li D, Jiao L, Porta M (2005) Epidemiology. In: von Hoff DD, Evans DB, Hruban RH (eds) Pancreatic cancer. Jones & Bartlett, Boston, pp 103-117
3. MM Hassan ML Bondy RA Wolff 2007 Risk factors for pancreatic cancer: case-control study Am J Gastroenterol 102 2696 2707 (Pubitemid 350179330)
4. AC Lo AS Soliman N El-Ghawalby 2007 Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk Pancreas 35 120 129 10.1097/mpa.0b013e318053e7d3
5. R Huxley A Ansary-Moghaddam A Berrington de Gonzalez F Barzi M Woodward 2005 Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies Br J Cancer 92 2076 2083 10.1038/sj.bjc.6602619
6. M Otsuki M Tashiro 2007 Chronic pancreatitis and pancreatic cancer, lifestyle-related diseases Intern Med 46 109 113 10.2169/internalmedicine.46. 1787
7. J Luo C Nordenvall O Nyrén HO Adami J Permert W Ye 2007 The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease Int J Cancer 120 368 372 10.1002/ijc.22123
8. S Gandini AB Lowenfels EM Jaffee TD Armstrong P Maisonneuve 2005 Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms Cancer Epidemiol Biomarkers Prev 14 1908 1916 10.1158/1055-9965.EPI-05-0119
9. DT Silverman M Schiffman J Everhart 1999 Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer Br J Cancer 80 1830 1837 10.1038/sj.bjc.6690607
10. E Efthimiou T Crnogorac-Jurcevic NR Lemoine TA Brentnall 2001 Inherited predisposition to pancreatic cancer Gut 48 143 147 (Pubitemid 32141832)
11. AB Lowenfels P Maisonneuve 2006 Epidemiology and risk factors for pancreatic cancer Best Pract Res Clin Gastroenterol 20 197 209 10.1016/j.bpg.2005.10.001
12. FX Real E Cibrián-Uhalte P Martinelli 2008 Pancreatic cancer development and progression: remodeling the model Gastroenterology 135 724 728 10.1053/j.gastro.2008.07.033
13. N Bardeesy RA DePinho 2002 Pancreatic cancer biology and genetics Nat Rev Cancer 2 897 909 (Pubitemid 37328891)
14. AF Hezel AC Kimmelman BZ Stanger N Bardeesy RA Depinho 2006 Genetics and biology of pancreatic ductal adenocarcinoma Genes Dev 20 1218 1249 10.1101/gad.1415606
15. A Maitra NV Adsay P Argani 2003 Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray Mod Pathol 16 902 912 10.1097/01.MP.0000086072.56290.FB
16. M Malumbres M Barbacid 2003 RAS oncogenes: the first 30 years Nat Rev Cancer 3 459 465 10.1038/nrc1097
17. M Porta N Malats M Jariod 1999 Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer Lancet 354 2125 2129 10.1016/S0140-6736(99)04232-4 (Pubitemid 30008897)
18. AS Soliman M Bondy CR Webb 2006 Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients Int J Cancer 119 1455 1461 10.1002/ijc.21986
19. RJ Slebos JA Hoppin PE Tolbert 2000 K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study Cancer Epidemiol Biomarkers Prev 9 1223 1232
20. JP Fryzek DH Garabrant M Schenk M Kinnard JK Greenson FH Sarkar 2006 The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations Int J Gastrointest Cancer 37 139 145
21. L Jiao J Zhu MM Hassan DB Evans JL Abbruzzese D Li 2007 K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking Pancreas 34 55 62 10.1097/01.mpa.0000246665.68869.d4
22. B Farrow Y Sugiyama A Chen E Uffort W Nealon BM Evers 2004 Inflammatory mechanisms contributing to pancreatic cancer development Ann Surg 239 763 771 10.1097/01.sla.0000128681.76786.07
23. M Karin 2005 Inflammation and cancer: the long reach of Ras Nat Med 11 20 21 10.1038/nm0105-20
24. A Sparmann D Bar-Sagi 2005 Ras oncogene and inflammation: partners in crime Cell Cycle 4 735 736 (Pubitemid 41353818)
25. R Schiel W Beltschikow T Steiner G Stein 2006 Diabetes, insulin, and risk of cancer Methods Find Exp Clin Pharmacol 28 169 175 10.1358/mf.2006.28.3. 985230
26. D Basso M Plebani P Fogar 1995 Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes Int J Clin Lab Res 25 40 43 10.1007/BF02592575
27. M Porta S Costafreda N Malats 2000 Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology Eur J Epidemiol 16 533 541 10.1023/A:1007692408457
28. M Porta N Malats L Guarner 1999 Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer J Epidemiol Community Health 53 702 709 (Pubitemid 29486177)
29. N Malats T Casals M Porta L Guarner X Estivill FX Real 2001 The cystic fibrosis transmembrane regulator (CFTR) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreas cancer Gut 48 70 74 (Pubitemid 32042644)
30. J Alguacil M Porta N Malats 2002 Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer Carcinogenesis 23 101 106 (Pubitemid 34213558)
31. FX Real N Malats G Lesca 2002 Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreas cancer Gut 50 653 657 (Pubitemid 34407492)
32. M Porta X Fabregat N Malats 2005 Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage Clin Transl Oncol 7 189 197
33. M Soler N Malats M Porta 1999 Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records Dig Dis Sci 44 2469 2477 (Pubitemid 30027363)
34. M Soler M Porta N Malats 1998 Learning from case-reports: diagnostic issues in an epidemiologic study of pancreatic cancer J Clin Epidemiol 51 1215 1221 (Pubitemid 29009521)
35. L Gavaldà M Porta N Malats 1995 Agreement between information supplied by the patient and a family member on medical history, consumption of tobacco, alcohol and coffee and diet in cancer of the exocrine pancreas and extrahepatic biliary tract Gac Sanit 9 334 342
36. M Crous-Bou M Porta T López 2007 Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer Pancreas 35 135 141 10.1097/mpa.0b013e31805d8fa4
37. PR Rosenbaum 2004 The case-only odds ratio as a causal parameter Biometrics 60 233 240 10.1111/j.0006-341X.2004.00154.x
38. Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research, 4th edn. Blackwell, Oxford
39. Rothman KJ, Greenland S, Lash TL (eds) (2008) Modern epidemiology, 3rd edn. Lippincott-Raven, Philadelphia
40. Bland M (1987) An introduction to medical statistics. Oxford Medical Publications, Oxford, pp 241-265
41. YX Ren GM Xu ZS Li YG Song 2004 Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases World J Gastroenterol 10 881 884
42. S Gansauge RM Schmid J Muller G Adler T Mattfeldt HG Beger 1998 Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations Br J Surg 85 337 340 (Pubitemid 28098618)
43. J Luttges A Diederichs MA Menke I Vogel B Kremer G Kloppel 2000 Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53 Cancer 88 2495 2504 (Pubitemid 30331955)
44. M Löhr G Kloppel P Maisonneuve AB Lowenfels J Luttges 2005 Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis Neoplasia 7 17 23 10.1593/neo.04445
45. C Guerra AJ Schuhmacher M Canamero 2007 Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-ras oncogenes in adult mice Cancer Cell 11 291 302 10.1016/j.ccr.2007.01.012
46. H Lu W Ouyang C Huang 2006 Inflammation, a key event in cancer development Mol Cancer Res 4 221 233 10.1158/1541-7786.MCR-05-0261
47. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 10.1038/nature01322
48. D Hanahan EF Wagner RD Palmiter 2007 The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer Genes Dev 21 2258 2270 10.1101/gad.1583307
49. M Porta N Malats J Vioque 2002 Incomplete overlapping of biological, clinical and environmental information in molecular epidemiologic studies: a variety of causes and a cascade of consequences J Epidemiol Community Health 56 734 738 10.1136/jech.56.10.734
50. M Porta N Malats JL Piñol J Rifà M Andreu FX Real 1994 Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer J Clin Epidemiol 47 1069 1079 10.1016/0895-4356(94)90123-6